Literature DB >> 28244885

Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.

Mark Schiffman1, Nicolas Wentzensen, Michelle J Khan, Philip E Castle, David Chelmow, Warner K Huh, Anna Barbara Moscicki, Colleen K Stockdale, Teresa M Darragh, Michelle Silver, Richard S Guido.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28244885      PMCID： PMC5365374          DOI： 10.1097/LGT.0000000000000300

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN： 1089-2591            Impact factor:   1.925


× No keyword cloud information.
  10 in total

1.  Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Authors:  Warner K Huh; Kevin A Ault; David Chelmow; Diane D Davey; Robert A Goulart; Francisco A Garcia; Walter K Kinney; L Stewart Massad; Edward J Mayeaux; Debbie Saslow; Mark Schiffman; Nicolas Wentzensen; Herschel W Lawson; Mark H Einstein
Journal:  J Low Genit Tract Dis       Date:  2015-04       Impact factor: 1.925

2.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

3.  2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

Authors:  L Stewart Massad; Mark H Einstein; Warner K Huh; Hormuzd A Katki; Walter K Kinney; Mark Schiffman; Diane Solomon; Nicolas Wentzensen; Herschel W Lawson
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

4.  Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.

Authors:  Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

Review 5.  Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.

Authors:  Nicolas Wentzensen; Marc Arbyn; Johannes Berkhof; Mark Bower; Karen Canfell; Mark Einstein; Christopher Farley; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2017-01-11       Impact factor: 7.396

Review 6.  2001 Consensus Guidelines for the management of women with cervical cytological abnormalities.

Authors:  Thomas C Wright; J Thomas Cox; L Stewart Massad; Leo B Twiggs; Edward J Wilkinson
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

7.  2006 consensus guidelines for the management of women with abnormal cervical screening tests.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  J Low Genit Tract Dis       Date:  2007-10       Impact factor: 1.925

8.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  J Low Genit Tract Dis       Date:  2007-10       Impact factor: 1.925

Review 9.  Triage of HPV positive women in cervical cancer screening.

Authors:  Nicolas Wentzensen; Mark Schiffman; Timothy Palmer; Marc Arbyn
Journal:  J Clin Virol       Date:  2015-11-28       Impact factor: 3.168

Review 10.  Carcinogenic human papillomavirus infection.

Authors:  Mark Schiffman; John Doorbar; Nicolas Wentzensen; Silvia de Sanjosé; Carole Fakhry; Bradley J Monk; Margaret A Stanley; Silvia Franceschi
Journal:  Nat Rev Dis Primers       Date:  2016-12-01       Impact factor: 52.329
  10 in total
  12 in total

1.  Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.

Authors:  Philip E Castle; Walter K Kinney; Xiaonan Xue; Li C Cheung; Julia C Gage; Nancy E Poitras; Thomas S Lorey; Hormuzd A Katki; Nicolas Wentzensen; Mark Schiffman
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

2.  Strategies for screening and early detection of anal cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers.

Authors:  Megan A Clarke; Nicolas Wentzensen
Journal:  Cancer Cytopathol       Date:  2018-05-24       Impact factor: 5.284

3.  Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.

Authors:  Mark Schiffman; Walter K Kinney; Li C Cheung; Julia C Gage; Barbara Fetterman; Nancy E Poitras; Thomas S Lorey; Nicolas Wentzensen; Brian Befano; John Schussler; Hormuzd A Katki; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

4.  A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populations.

Authors:  Hormuzd A Katki; Mark Schiffman
Journal:  Prev Med       Date:  2018-02-14       Impact factor: 4.018

5.  A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.

Authors:  Nicolas Wentzensen; Joan Walker; Katie Smith; Michael A Gold; Rosemary Zuna; L Stewart Massad; Angela Liu; Michelle I Silver; S Terence Dunn; Mark Schiffman
Journal:  Am J Obstet Gynecol       Date:  2018-02-17       Impact factor: 8.661

6.  The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity?

Authors:  Phil Castle; Sarah Feldman; Rebecca B Perkins
Journal:  J Low Genit Tract Dis       Date:  2018-04       Impact factor: 1.925

7.  Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.

Authors:  Maria Demarco; Thomas S Lorey; Barbara Fetterman; Li C Cheung; Richard S Guido; Nicolas Wentzensen; Walter K Kinney; Nancy E Poitras; Brian Befano; Philip E Castle; Mark Schiffman
Journal:  J Low Genit Tract Dis       Date:  2017-10       Impact factor: 1.925

8.  Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic Pathology.

Authors:  Sharyl J Nass; Michael B Cohen; Ritu Nayar; Mary M Zutter; Erin P Balogh; Richard L Schilsky; Hedvig Hricak; Kojo S J Elenitoba-Johnson
Journal:  Oncologist       Date:  2019-07-31

9.  Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.

Authors:  Chyke A Doubeni; Nicole B Gabler; Cosette M Wheeler; Anne Marie McCarthy; Philip E Castle; Ethan A Halm; Mitchell D Schnall; Celette S Skinner; Anna N A Tosteson; Donald L Weaver; Anil Vachani; Shivan J Mehta; Katharine A Rendle; Stacey A Fedewa; Douglas A Corley; Katrina Armstrong
Journal:  CA Cancer J Clin       Date:  2018-03-30       Impact factor: 508.702

10.  An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Authors:  Mark Schiffman; Nicolas Wentzensen; Rebecca B Perkins; Richard S Guido
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.